scispace - formally typeset
Open AccessJournal ArticleDOI

High prevalence of CIC fusion with double-homeobox (DUX4) transcription factors in EWSR1-negative undifferentiated small blue round cell sarcomas

Reads0
Chats0
TLDR
The results suggest the possibility of a newly defined subgroup of primitive round cell sarcomas characterized by CIC rearrangements, distinct from Ewing sarcoma family of tumors.
Abstract
Primitive round cell sarcomas of childhood and young adults have been problematic to diagnose and classify. Our goal was to investigate the pathologic and molecular characteristics of small blue round cell tumors (SBRCT) that remained unclassified after exhaustive immunohistochemistry and molecular screening to exclude known sarcoma-related translocations. As rare examples of EWSR1-negative SBRCT have been shown to carry rearrangements for FUS and CIC genes, we undertook a systematic screening for these two genes. CIC rearrangements by FISH were detected in 15/22 (68%), while none showed FUS abnormalities. RACE, RT-PCR, and/or long-range DNA PCR performed in two cases with frozen material showed that CIC was fused to copies of the DUX4 gene on either 4q35 or 10q26.3. Subsequent FISH analysis confirmed fused signals of CIC with either 4q35 or 10q26.3 region in six cases each. Tumors positive for CIC-DUX4 fusion occurred mainly in male young adult patients (median age: 29 years), with the extremities being the most frequent location. Microscopically, tumors displayed a primitive, round to oval cell morphology with prominent nucleoli, high mitotic count, and areas of necrosis. O13 expression was variable, being either diffuse or patchy and tumors mostly lacked other markers of differentiation. Although CIC-DUX4 resulting in a t(4;19) translocation has been previously described in primitive sarcomas, this is the first report implicating the related DUX4 on 10q26 in oncogenesis. These results suggest the possibility of a newly defined subgroup of primitive round cell sarcomas characterized by CIC rearrangements, distinct from Ewing sarcoma family of tumors.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

The evolving classification of soft tissue tumours – an update based on the new 2013 WHO classification

TL;DR: A brief overview summarizes changes in the classification in each of the broad categories of soft tissue tumour (adipocytic, fibroblastic, etc.) and also provides a short summary of newer genetic data which have been incorporated in the WHO classification.
Journal ArticleDOI

WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition.

TL;DR: The fourth edition of the World Health Organization (WHO) Classification of Tumours of Soft Tissue and Bone was published in February 2013, and serves to provide an updated classification scheme and reproducible diagnostic criteria for pathologists.
Journal ArticleDOI

Sarcoma classification: an update based on the 2013 World Health Organization Classification of Tumors of Soft Tissue and Bone.

TL;DR: Changes in the classification of soft tissue and bone sarcomas as well as tumors of intermediate biologic potential in the 2013 World Health Organization volume are reviewed, new molecular insights into these tumors, and associated surgical and clinical implications are reviewed.
Journal ArticleDOI

The genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation

TL;DR: The largest genomic survey to date of 101 EFT (65 tumors and 36 cell lines) is reported, finding that EFT has a very low mutational burden but frequent deleterious mutations in the cohesin complex subunit STAG2 and that 11% of tumors pathologically diagnosed as EFT lack a typical EWSR1 fusion oncogene and these tumors do not have a characteristic Ewing sarcoma gene expression signature.
Journal ArticleDOI

Refinements in Sarcoma Classification in the Current 2013 World Health Organization Classification of Tumours of Soft Tissue and Bone

TL;DR: The fourth edition of the World Health Organization (WHO) Classification of Tumours of Soft Tissue and Bone was published in February 2013 and provides an updated classification scheme and reproducible diagnostic criteria, based on recent clinicopathologic studies and genetic and molecular data.
References
More filters
Journal ArticleDOI

A Unifying Genetic Model for Facioscapulohumeral Muscular Dystrophy

TL;DR: It is shown that FSHD patients carry specific single-nucleotide polymorphisms in the chromosomal region distal to the last D4Z4 repeat that creates a canonical polyadenylation signal for transcripts derived from DUX4, a double homeobox gene of unknown function that straddles the last repeat unit and the adjacent sequence.
Journal ArticleDOI

Ewing's sarcoma

TL;DR: The EWS-ETS family of gene fusions and their downstream effects in Ewing's sarcomas provide opportunities for new approaches to treatment, including the inhibition of the fusion gene or its protein product, and pathways related to IGF1 and mTOR.
Journal Article

A variant ewing's sarcoma translocation (7;22) fuses the ews gene to the ets gene etv1

TL;DR: A third Ewing's sarcoma translocation is identified, the t(7;22)(p22;q12), that fuses EWS to the human homologue of the murine ETS gene ER81, and this gene, designated ETV1 (for ETS Translocation Variant), is located on chromosome band 7p22.
Journal ArticleDOI

Facioscapulohumeral Dystrophy: Incomplete Suppression of a Retrotransposed Gene

TL;DR: It is shown that FSHD muscle expresses a different splice form of DUX4 mRNA compared to control muscle, which indicates that full-length Dux4 is normally expressed at specific developmental stages and is suppressed in most somatic tissues.
Journal ArticleDOI

EWSR1‐POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty‐six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene

TL;DR: It is found that a subset of soft tissue ME tumors with clear cell morphology harbor an EWSR1‐POU5F1 fusion, which can be used as a molecular diagnostic test in difficult cases, and these findings do not support a pathogenetic relationship between soft tissue Me tumors and their salivary gland counterparts.
Related Papers (5)